Slow but steady: Anesthesiology researcher with more than 100 retractions will earn two more

Ludwigshafen Hospital, via Wikimedia

Score one for responsiveness. 

In mid-May, we reported on the retraction of three review articles by Joachim Boldt, whose papers continue to fall despite his having been exposed as a fraudster a decade ago. At the time, we wondered why another journal, Anesthesia & Analgesia, hadn’t also pulled reviews by Boldt that it had published over the years.  

Now, it has. 

Continue reading Slow but steady: Anesthesiology researcher with more than 100 retractions will earn two more

Race to be first to report first case of COVID-19 death during pregnancy leads to a retraction

A group of researchers in Iran has retracted their case report on what they claimed was the first known case of a pregnant woman who died of Covid-19. 

The reason: According to the corresponding author, another group of researchers in Iran, who had first seen the patient at their hospital, had beaten them to the submission punch without their knowledge. (This isn’t the first time we’ve seen a case like this.)

The paper appeared in Travel Medicine and Infectious Disease, an Elsevier title, on April 11. Sometime in early May, it seems (the dates are unclear on the journal website) the group, led by a team at Zanjan University of Medical Sciences, retracted the article. 

Elsevier allows authors to withdraw papers without explanation if they have appeared online but not yet in print, which is the case here. So the retraction notice says, well, nothing: 

Continue reading Race to be first to report first case of COVID-19 death during pregnancy leads to a retraction

NEJM, Lancet place expressions of concern on controversial studies of drugs for COVID-19

[See update on this story.]

As controversy swirls around two papers that used data from Surgisphere, the New England Journal of Medicine and The Lancet have placed expression of concerns on the relevant papers.

Here’s the NEJM expression of concern:

Continue reading NEJM, Lancet place expressions of concern on controversial studies of drugs for COVID-19

Anesthesiology group loses ten papers at once in one journal

A group of anesthesiology researchers in India has had 10 papers retracted from a single journal because of a “high rate of similarity from various other articles along with overwhelming evidence of data fabrication.”

The retractions came after one of the authors of the papers submitted a manuscript to a different journal whose editor sniffed out issues and raised a red flag.

The Saudi Journal of Anesthesia has retracted ten articles by Anjan Das, of Kolkata, and colleagues:

Continue reading Anesthesiology group loses ten papers at once in one journal

Top journal retracts study claiming masks ineffective in preventing COVID-19 spread

Source

One of the world’s leading medical journals has retracted a widely circulated paper published in April that concluded that “both surgical and cotton masks seem to be ineffective in preventing the dissemination of SARS–CoV-2 from the coughs of patients with COVID-19 to the environment and external mask surface.”

The study, published by the Annals of Internal Medicine, has been cited by dozens of news stories, nearly 10,000 Twitter users — some of whom raised red flags about its methods — and by the World Health Organization.

But it turns out that the authors failed to consider the limits of the test they were using to detect the presence of coronavirus.

The paper only involved four participants. Apparently, the authors thought a correction — adding more patients — would be enough:

Continue reading Top journal retracts study claiming masks ineffective in preventing COVID-19 spread

Nature retracts study touted as step toward treatments for bone diseases

A Nature study that could have provided a “potential therapeutic target for osteoporosis and bone metastases of cancer” has been retracted.

Since being published in 2014 by researchers at UT Southwestern, MD Anderson and elsewhere, “miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2” has been cited more than 200 times, according to Clarivate Analytics’ Web of Science.

A year ago — on May 24, 2019 — Nature published a correction to the paper:

Continue reading Nature retracts study touted as step toward treatments for bone diseases

‘Negligence’ — a lot of it — leads to a retraction

Source

Some words do more work in sentences than others. Take the example of the word  “negligence,” which in the case of the following retraction notice is a veritable beast of burden.

The 2019 article, “Conservative management of subglottic stenosis with home based tracheostomy care: A retrospective review of 28 patients,” appeared in the International Journal of Pediatric Otorhinolaryngology, an Elsevier title. The authors, led by Andrew Pelser, have affiliations in the United Kingdom and South Africa — a fact that appears to be non-trivial. 

Per the abstract: 

Continue reading ‘Negligence’ — a lot of it — leads to a retraction

Weekend reads: Hydroxychloroquine paper earns correction; company allegedly fakes COVID-19 data; why retractions fail

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance.

The week at Retraction Watch featured:

How many papers about COVID-19 have been retracted? We’ve been keeping track, as part of our database. Here’s our frequently updated list.

Here’s what was happening elsewhere:

Continue reading Weekend reads: Hydroxychloroquine paper earns correction; company allegedly fakes COVID-19 data; why retractions fail

A convicted felon wants people to enroll in a COVID-19 clinical trial. What could go wrong?

Richard Fleming

Richard Fleming, a felon convicted of health care fraud who has been debarred by the US Food and Drug Administration, would like to invite you to participate in a clinical trial.

Fleming has registered a study on ClinicalTrials.gov to evaluate what he calls the “Fleming Method for Tissue and Vascular Differentiation and Metabolism” — a method he claims can help physicians assess pneumonia resulting from Covid-19. 

According to the notes for the study

Continue reading A convicted felon wants people to enroll in a COVID-19 clinical trial. What could go wrong?

A journal publishes a critical letter — then says it was a mistake

On Sept. 17, 2019, virologist David Sanders — who recently won a lawsuit brought against him for efforts as a scientific sleuth — wrote a letter to the Journal of Cellular Physiology about a 2004 paper whose images raised his eyebrows.

The response a day later from an editorial assistant was a hint of what was to come:

Continue reading A journal publishes a critical letter — then says it was a mistake